glp-1 liquid drops side effects Adverse of Receptor Agonists RACGP - Unregulated GLP-1 access
Description
We want to change that
Peaka GLP-1 vs prescription GLP-1 medications Comparing Peaka GLP-1 to prescription GLP-1 medications reveals the enormous gulf between supplement marketing claims and pharmaceutical reality

This approach significantly increases the bioavailability of the drug when taken orally

Yet peptide-based GLP-1 products are far from being replaced they will achieve long-term, complementary coexistence with small molecules via differentiated innovation

Among those who are not interested, top reasons include not being overweight/diabetic, being concerned with the side effects, and general skepticism about drugs

Diabetes Care 48(1):S207-38 Marx N, Federici M, Schtt K, Mller-Wieland D, Ajjan RA, Antunes MJ et al (2023) 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
